JPMorgan Chase Financial Company LLC has disclosed a preliminary pricing supplement for Auto Callable Contingent Interest Notes linked to the MerQube US Gold Vol Advantage Index, with an expected maturity date of August 3, 2029. The structured investment product is designed for investors seeking contingent interest payments tied to index performance, though investors face significant downside risk if the index declines substantially. The notes are fully guaranteed by JPMorgan Chase & Co. and carry a minimum denomination of $1,000.

Key Points

  • NYSE: VYLD
  • JPMorgan Chase Financial Company LLC unveiled Auto Callable Contingent Interest Notes tied to the MerQube US Gold Vol Advantage Index due August 3, 2029
  • Notes expected to price on or about July 31, 2026, and settle on or about August 5, 2026; minimum denomination $1,000 with CUSIP 46661KSJ8
  • Contingent interest payments of at least 1.16667% monthly (at least 14.00% per annum) if index closes at or above 65.00% of initial value on any review date
  • Automatic call feature triggered if index reaches 90.00% of initial value on any review date between August 2, 2027 and July 31, 2029; potential principal loss exceeds 35.00% if index falls below trigger value at maturity

Structure and Contingent Payment Mechanics

The notes are designed with a contingent interest payment feature that rewards investors if the MerQube US Gold Vol Advantage Index maintains strength relative to its initial value at specific review dates. According to the disclosure, investors will receive contingent interest payments equal to at least $11.6667 per $1,000 principal amount note—equivalent to at least 1.16667% per month or at least 14.00% per annum—if the closing level of the index on any review date is greater than or equal to 65.00% of the initial value, referred to as the interest barrier. These payments are contingent on the notes not having been automatically called at that point.

The pricing supplement specifies that if the closing level of the index on any review date falls below the interest barrier, no contingent interest payment will be made for that particular review date. This structure introduces timing risk, as investors may experience periods without interest payments if index performance weakens. The notes offer no fixed interest rate; investors forgo conventional coupon payments in exchange for the opportunity to receive the higher contingent payments. The disclosure emphasizes that investors should be willing to accept the risk that no contingent interest payment may be made with respect to some or all review dates during the note's life.

Automatic Call Feature and Early Redemption

The notes incorporate an automatic call provision that allows JPMorgan Chase Financial to redeem the notes early if the index performs strongly. According to the filing, the notes will be automatically called if the closing level of the index on any review date (excluding the first through eleventh and final review dates) is greater than or equal to the call value of 90.00% of the initial value. The earliest date on which an automatic call may be initiated is August 2, 2027, meaning the initial review dates in late 2026 and early 2027 are protected from automatic redemption.

Upon automatic call, investors will receive a cash payment equal to $1,000 principal plus the contingent interest payment applicable to that review date, with settlement occurring on the applicable call settlement date. The disclosure clarifies that no further payments will be made on the notes once they are automatically called. This feature benefits the issuer if the index rises significantly, as it allows JPMorgan Financial to cap its contingent interest obligations. However, this also limits investor upside if the index rallies substantially, since redemption occurs at par plus only one final contingent interest payment rather than allowing continued participation in index gains.

Index Characteristics and Daily Deduction Impact

The MerQube US Gold Vol Advantage Index, which trades under Bloomberg ticker MQUSGVA, incorporates a structural feature that materially affects investor returns. The filing discloses that the index level reflects a deduction of 6.0% per annum that accrues daily. This daily deduction will offset any appreciation of the futures contracts included in the index and will heighten depreciation if the index declines, creating a performance drag that affects both positive and negative scenarios for note holders.

The impact of this deduction is particularly significant for investors evaluating total return potential. The pricing supplement explicitly states that the index will trail the performance of an identical index without a deduction, meaning the 6.0% per annum daily drag reduces the effective performance that investors benefit from during the note term. This structural feature is classified as a key risk consideration in the disclosure, as it operates independently of market movements to reduce the index level over time. Investors considering these notes should factor this ongoing deduction into their analysis of potential index movements and corresponding note returns.

Maturity Mechanics and Principal Risk

The notes mature on August 3, 2029, at which point investors will receive either full par value plus a final contingent interest payment, or a reduced payment reflecting index losses. According to the disclosure, if the notes have not been automatically called and the final value of the index is greater than or equal to the trigger value of 65.00% of the initial value, the investor receives $1,000 principal plus the contingent interest payment applicable to the final review date. This scenario represents the most favorable outcome at maturity.

However, if the notes remain uncalled and the final index value falls below the trigger value, the payment structure becomes substantially less favorable. The disclosure specifies that the maturity payment would be calculated as $1,000 plus ($1,000 multiplied by the index return), where index return equals the change in the index from its initial value to final value, divided by the initial value. Critically, the filing warns that if the final value is less than the trigger value, investors will lose more than 35.00% of principal at maturity and could lose all principal if the index declines sufficiently. This downside protection threshold at 65.00% means that any index decline exceeding 35.00% from initial value results in principal loss, with no floor protecting investors from total capital loss.

Pricing, Settlement, and Cost Structure

The notes carry a minimum denomination of $1,000 and integral multiples thereof, establishing a significant entry price for individual investors. The pricing supplement indicates that the notes are expected to price on or about July 31, 2026, with an expected settlement date of on or about August 5, 2026. The filing specifies that if the notes priced on the announcement date, the estimated value would be approximately $950.00 per $1,000 principal amount note, suggesting an embedded cost or discount reflecting the issuer's hedging expenses and profit margin.

The disclosure notes that when the terms of the notes are definitively set, the estimated value provided in the final pricing supplement will not be less than $930.00 per $1,000 principal amount note. This establishes a floor on estimated value but indicates that investors may pay a premium over this estimated value depending on market conditions at pricing. Selling commissions paid by J.P. Morgan Securities LLC to dealers will not exceed $7.50 per $1,000 principal amount note. The pricing supplement references "Supplemental Use of Proceeds" for information about components of the public price, though specific breakdowns of fees and commissions were not completed in this preliminary disclosure.

Review Dates and Interest Payment Schedule

The notes incorporate a detailed schedule of 37 review dates spanning from August 31, 2026, through July 31, 2029, the final review date. According to the filing, review dates occur roughly monthly with some spacing variations, including dates such as August 31, September 30, November 2, and December 31 in 2026, continuing through various dates in 2027, 2028, and 2029. Corresponding interest payment dates follow several business days after each review date, with the initial interest payment date scheduled for September 3, 2026, and subsequent payments flowing through the note term.

This frequent review schedule means that contingent interest payments potentially occur monthly, subject to the index level condition at each determination point. The predictable schedule allows investors to anticipate when index levels will be assessed and when payments would be received or forfeited. However, the high frequency of testing dates also increases exposure to negative determinations, as the index must exceed the interest barrier on each occasion for full contingent interest to accrue. The disclosure subject to postponement language indicates that review dates and interest payment dates may be adjusted in the event of market disruption events, introducing some scheduling uncertainty into the interest payment stream.

Credit Support and Guarantee Structure

JPMorgan Chase Financial Company LLC serves as the issuer of the notes, with JPMorgan Chase & Co. providing a full and unconditional guarantee of all payments. The pricing supplement emphasizes that the notes are unsecured and unsubordinated obligations of JPMorgan Financial, meaning they are not backed by specific assets or collateral. However, investors benefit from the credit strength of JPMorgan Chase & Co., one of the United States' largest financial institutions, standing behind the obligations.

The filing explicitly warns that any payment on the notes is subject to the credit risk of JPMorgan Financial as the primary issuer and the credit risk of JPMorgan Chase & Co. as guarantor. This dual credit exposure means that investors rely on both entities' creditworthiness; however, in practical terms, JPMorgan Chase & Co.'s guarantee provides a significant cushion given its size and financial stability. The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency, and are not obligations of or guaranteed by a bank in the traditional sense, distinguishing them from deposit products. The disclosure emphasizes these distinctions to ensure investors understand the structured nature of their investment.

Risk Considerations for Prospective Investors

The pricing supplement identifies principal loss as a central risk consideration, warning that investors should be willing to accept the risk of losing a significant portion or all of their principal. The filing emphasizes that if the index falls below the 65.00% trigger value by maturity, investors experience substantial capital erosion, with potential losses exceeding 35.00% of principal and extending to complete capital loss under adverse scenarios. This risk is inherent to the structure and cannot be mitigated by the issuer's creditworthiness, as the guarantee extends only to JPMorgan Financial's ability to make contractual payments based on the formula, not to prevent index declines.

Beyond principal risk, the disclosure highlights the 6.0% per annum daily deduction as a persistent performance drag that reduces investor gains in positive market environments while amplifying losses in negative ones. The structured nature of the notes—lacking fixed interest payments while bearing full downside equity-like risk—introduces complexity that may not suit all investor profiles. The filing notes that these notes are not suitable for investors seeking capital preservation, fixed income, or principal protection. Additionally, investors must monitor the review dates and interest barrier calculations throughout the note term, as missing contingent interest payments can accumulate if the index trades below the barrier on successive review dates. The possibility of automatic early redemption if the index rises sharply further limits investors' ability to participate in strong market rallies.

Registration and Compliance Framework

The pricing supplement is filed under Registration Statement Nos. 333-293684 and 333-293684-01 pursuant to Rule 424(b)(2) of the Securities Act of 1933. The document bears a preliminary pricing supplement marking and is dated July 17, 2026, with an expectation of completion. The disclosure explicitly states that the information contained is not complete and may be changed, and that this preliminary supplement is not an offer to sell nor does it seek an offer to buy the securities in any jurisdiction where the offer or sale is not permitted. The filing notes that neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or adequacy of the disclosure documents.

The CUSIP number for the notes is provided as 46661KSJ8, enabling investors and financial professionals to identify and track these specific securities through quotation systems and trading platforms. The pricing supplement references accompanying product supplement no. 3-I dated April 17, 2026, underlying supplement no. 5-I dated April 17, 2026, and prospectus and prospectus supplement documents, also dated April 17, 2026. These accompanying documents provide additional detail on risk factors, general terms of the notes, and terms specific to index-linked structured investments. The comprehensive disclosure framework is designed to ensure investors have access to complete information regarding the product's mechanics, risks, and the issuer's creditworthiness before committing capital.